Henry R. Tribble

755 total citations
22 papers, 634 citations indexed

About

Henry R. Tribble is a scholar working on Immunology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Henry R. Tribble has authored 22 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 6 papers in Oncology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Henry R. Tribble's work include Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (8 papers) and Viral Infections and Immunology Research (4 papers). Henry R. Tribble is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (8 papers) and Viral Infections and Immunology Research (4 papers). Henry R. Tribble collaborates with scholars based in United States and Netherlands. Henry R. Tribble's co-authors include James E. Talmadge, Hamblin Phillips, Robin Pennington, Robert H. Wiltrout, Denny Liggitt, John Schindler, H. Michael Shepard, Mark Schneider, Barbara Lenz and Cedric W. Long and has published in prestigious journals such as Blood, The Journal of Immunology and The Journal of Infectious Diseases.

In The Last Decade

Henry R. Tribble

21 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry R. Tribble United States 12 326 216 192 72 67 22 634
Richard D. Maca United States 15 273 0.8× 131 0.6× 207 1.1× 71 1.0× 41 0.6× 33 722
Ugur Üçer Germany 10 589 1.8× 176 0.8× 227 1.2× 120 1.7× 54 0.8× 17 869
Moshe Glaser United States 19 632 1.9× 267 1.2× 232 1.2× 91 1.3× 140 2.1× 40 1.0k
R Breslow United States 9 497 1.5× 239 1.1× 295 1.5× 30 0.4× 54 0.8× 15 1.1k
E L Larsson Sweden 14 544 1.7× 110 0.5× 217 1.1× 164 2.3× 50 0.7× 29 900
K J Hardy United States 12 357 1.1× 136 0.6× 186 1.0× 27 0.4× 33 0.5× 15 569
Jean M. Decker United States 8 303 0.9× 137 0.6× 234 1.2× 36 0.5× 40 0.6× 10 680
John Leslie Collins United States 15 491 1.5× 143 0.7× 262 1.4× 52 0.7× 105 1.6× 48 964
Richard S. Schulof United States 15 249 0.8× 140 0.6× 152 0.8× 109 1.5× 20 0.3× 30 657
R. Obrist Switzerland 14 237 0.7× 141 0.7× 138 0.7× 103 1.4× 39 0.6× 47 610

Countries citing papers authored by Henry R. Tribble

Since Specialization
Citations

This map shows the geographic impact of Henry R. Tribble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry R. Tribble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry R. Tribble more than expected).

Fields of papers citing papers by Henry R. Tribble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry R. Tribble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry R. Tribble. The network helps show where Henry R. Tribble may publish in the future.

Co-authorship network of co-authors of Henry R. Tribble

This figure shows the co-authorship network connecting the top 25 collaborators of Henry R. Tribble. A scholar is included among the top collaborators of Henry R. Tribble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry R. Tribble. Henry R. Tribble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Black, Paul L., Hamblin Phillips, Henry R. Tribble, et al.. (1993). Antitumor response to recombinant murine interferon ? correlates with enhanced immune function of organ-associated, but not recirculating cytolytic T lymphocytes and macrophages. Cancer Immunology Immunotherapy. 37(5). 299–306. 7 indexed citations
3.
Black, Paul L., D Hartmann, Robin Pennington, et al.. (1992). Effect of tumor burden and route of administration on the immunotherapeutic properties of polyinosinic-polycytidylic acid stabilized with poly-l-lysine in carboxymethyl cellulose [Poly(I,C)-LC]. International Journal of Immunopharmacology. 14(8). 1341–1353. 13 indexed citations
4.
Smyth, Mark J., Dan L. Longo, William C. Kopp, et al.. (1992). Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cells. The Journal of Immunology. 149(3). 949–956. 81 indexed citations
5.
Talmadge, James E., et al.. (1989). Therapeutic and Toxic Activity of Tumor Necrosis Factor Is Synergistic with Gamma Interferon. Pathology and Immunopathology Research. 8(1). 21–34. 13 indexed citations
6.
Talmadge, James E., et al.. (1989). Protective, restorative, and therapeutic properties of recombinant colony-stimulating factors. Blood. 73(8). 2093–2103. 4 indexed citations
7.
Schneider, Marc, Jennifer Keller, F W Ruscetti, et al.. (1989). Myelostimulatory activity of recombinant human interleukin-2 in mice. Blood. 73(6). 1458–1467.
8.
Talmadge, James E., et al.. (1989). Protective, restorative, and therapeutic properties of recombinant colony-stimulating factors. Blood. 73(8). 2093–2103. 39 indexed citations
9.
Schneider, Marc, Jennifer Keller, F W Ruscetti, et al.. (1989). Myelostimulatory activity of recombinant human interleukin-2 in mice. Blood. 73(6). 1458–1467. 15 indexed citations
10.
Black, Paul L., Hamblin Phillips, Henry R. Tribble, et al.. (1988). Correlation of immunomodulatory and therapeutic activities of interferon and interferon inducers in metastatic disease. Journal of Cellular Biochemistry. 36(4). 377–392. 8 indexed citations
11.
Talmadge, James E., Henry R. Tribble, Robin Pennington, Hamblin Phillips, & Robert H. Wiltrout. (1987). Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.. PubMed. 47(10). 2563–70. 110 indexed citations
12.
Talmadge, James E., et al.. (1987). Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.. PubMed. 128(3). 410–25. 86 indexed citations
13.
Talmadge, James E., Hamblin Phillips, John Schindler, Henry R. Tribble, & Robin Pennington. (1987). Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease.. PubMed. 47(21). 5725–32. 81 indexed citations
14.
Tribble, Henry R., et al.. (1971). Replication of Venezuelan Equine Encephalomyelitis Virus In Vitro. Applied Microbiology. 21(2). 342–345. 5 indexed citations
15.
Tribble, Henry R., et al.. (1971). Replication of Venezuelan Equine Encephalomyelitis Virus In Vitro. Applied Microbiology. 21(2). 342–345. 2 indexed citations
16.
Tribble, Henry R., et al.. (1971). Replication of Venezuelan Equine Encephalomyelitis Virus in Suspension Cell Cultures Grown in Serum-free and Defined Media. Journal of General Virology. 10(3). 231–236. 5 indexed citations
17.
Tribble, Henry R., et al.. (1967). Inactivation of Venezuelan Equine Encephalomyelitis Virus by γ-Radiation. Applied Microbiology. 15(6). 1456–1459. 1 indexed citations
18.
Tribble, Henry R., et al.. (1967). Inactivation of Venezuelan Equine Encephalomyelitis Virus by γ-Radiation. Applied Microbiology. 15(6). 1456–1459. 11 indexed citations
19.
Tribble, Henry R., et al.. (1963). A Chemically Defined Medium for Growth of Animal Cells in Suspension. Experimental Biology and Medicine. 112(2). 340–344. 34 indexed citations
20.
Tribble, Henry R. & Kiyoshi Higuchi. (1963). Studies on the nutrition and metabolism of animal cells in serum-free media: II. Cultivation of cells in suspension. The Journal of Infectious Diseases. 112(3). 221–225. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard D. Maca Breakdown of academic impact, for papers by Ugur Üçer Breakdown of academic impact, for papers by Moshe Glaser Breakdown of academic impact, for papers by R Breslow Breakdown of academic impact, for papers by E L Larsson Breakdown of academic impact, for papers by K J Hardy Breakdown of academic impact, for papers by Jean M. Decker Breakdown of academic impact, for papers by John Leslie Collins Breakdown of academic impact, for papers by Richard S. Schulof Breakdown of academic impact, for papers by R. Obrist
Rankless by CCL
2026